Glyconics
4 known investors
Find your way into Glyconics
Sign up to see every warm intro you have to Glyconics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Glyconics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
Founders & leadership
AR

Andrew RoundChief Executive Officer (ad interim)
DP

Dr. Päivi Maria PaldániusChief Medical Officer & Chief Operating Officer
SC
Sebastien Cuvelier MussalianChief Technology Officer
DP

Dr. Phil TadayHead of R&D
PJ
Paul JessonChief Finance Officer
Investors · 4
Anglia Capital Grouplisted by Anglia Capital GroupNorwich
How we know: Anglia Capital Group's portfolio page · Not right? Tell us
Also in the syndicate · 1
Wealth Clublead
Funding
SEC filings, press & company announcements- Undisclosed amountEnterprise Investment Scheme (EIS) funding roundNov 2021 · 2 sources
Deepbridge Capital (lead), Wealth Club (lead), Boundary Capital
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Glyconics do?
- Glyconics develops medical diagnostic devices using spectroscopy (light-with-matter technology) to support low-cost medical diagnosis and disease management for patients and healthcare practice.
- Who are Glyconics's investors?
- Glyconics's investors include Anglia Capital Group, Boundary Capital, Deepbridge Capital.
